CA2189486A1 - Analyse de l'activite enzymatique utilisant des substrats immobilises, marques par fluorescence - Google Patents

Analyse de l'activite enzymatique utilisant des substrats immobilises, marques par fluorescence

Info

Publication number: CA2189486A1
Authority: CA; Canada
Prior art keywords: microspheres; activity; gelatinase; substrate; fitc
Prior art date: 1996-11-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2189486

Other languages

English (en)

Inventor

Yves St-Pierre

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-04

Filing date

1996-11-04

Publication date

1998-05-04

1996-11-04 Application filed by Individual filed Critical Individual

1996-11-04 Priority to CA 2189486 priority Critical patent/CA2189486A1/fr

1997-11-04 Priority to EP97911088A priority patent/EP0951562A1/fr

1997-11-04 Priority to AU48595/97A priority patent/AU4859597A/en

1997-11-04 Priority to PCT/CA1997/000823 priority patent/WO1998020153A1/fr

1997-11-04 Priority to CA 2220656 priority patent/CA2220656A1/fr

1998-05-04 Publication of CA2189486A1 publication Critical patent/CA2189486A1/fr

Status Abandoned legal-status Critical Current

Links

239000000758 substrate Substances 0.000 title description 73
230000000694 effects Effects 0.000 title description 43
102000004190 Enzymes Human genes 0.000 title description 40
108090000790 Enzymes Proteins 0.000 title description 40
238000004458 analytical method Methods 0.000 title description 10
239000004005 microsphere Substances 0.000 description 75
238000000034 method Methods 0.000 description 42
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 41
229940088598 enzyme Drugs 0.000 description 39
238000003556 assay Methods 0.000 description 37
102000001776 Matrix metalloproteinase-9 Human genes 0.000 description 35
108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 35
230000002255 enzymatic effect Effects 0.000 description 29
239000008273 gelatin Substances 0.000 description 24
229920000159 gelatin Polymers 0.000 description 24
108010010803 Gelatin Proteins 0.000 description 21
235000019322 gelatine Nutrition 0.000 description 21
235000011852 gelatine desserts Nutrition 0.000 description 21
238000000684 flow cytometry Methods 0.000 description 20
102000002274 Matrix Metalloproteinases Human genes 0.000 description 18
108010000684 Matrix Metalloproteinases Proteins 0.000 description 18
239000002245 particle Substances 0.000 description 17
239000000523 sample Substances 0.000 description 17
239000003112 inhibitor Substances 0.000 description 15
235000018102 proteins Nutrition 0.000 description 15
102000004169 proteins and genes Human genes 0.000 description 15
108090000623 proteins and genes Proteins 0.000 description 15
239000003153 chemical reaction reagent Substances 0.000 description 14
239000004793 Polystyrene Substances 0.000 description 12
210000004027 cell Anatomy 0.000 description 12
229920002223 polystyrene Polymers 0.000 description 12
238000001514 detection method Methods 0.000 description 10
230000035945 sensitivity Effects 0.000 description 10
239000011324 bead Substances 0.000 description 9
239000012472 biological sample Substances 0.000 description 9
230000015556 catabolic process Effects 0.000 description 9
102000035195 Peptidases Human genes 0.000 description 8
108091005804 Peptidases Proteins 0.000 description 8
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
238000006731 degradation reaction Methods 0.000 description 8
238000002474 experimental method Methods 0.000 description 8
238000002372 labelling Methods 0.000 description 8
238000012360 testing method Methods 0.000 description 8
238000005259 measurement Methods 0.000 description 7
239000007787 solid Substances 0.000 description 7
239000000126 substance Substances 0.000 description 7
238000007805 zymography Methods 0.000 description 7
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 6
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 6
206010028980 Neoplasm Diseases 0.000 description 6
BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 6
210000002744 extracellular matrix Anatomy 0.000 description 6
230000005764 inhibitory process Effects 0.000 description 6
230000003287 optical effect Effects 0.000 description 6
108091003079 Bovine Serum Albumin Proteins 0.000 description 5
108020004414 DNA Proteins 0.000 description 5
102000013382 Gelatinases Human genes 0.000 description 5
108010026132 Gelatinases Proteins 0.000 description 5
230000008901 benefit Effects 0.000 description 5
230000000903 blocking effect Effects 0.000 description 5
239000005018 casein Substances 0.000 description 5
238000003776 cleavage reaction Methods 0.000 description 5
239000011248 coating agent Substances 0.000 description 5
238000000576 coating method Methods 0.000 description 5
201000010099 disease Diseases 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
239000003814 drug Substances 0.000 description 5
238000012544 monitoring process Methods 0.000 description 5
230000007017 scission Effects 0.000 description 5
108090000364 Ligases Proteins 0.000 description 4
102000003960 Ligases Human genes 0.000 description 4
239000000427 antigen Substances 0.000 description 4
102000036639 antigens Human genes 0.000 description 4
108091007433 antigens Proteins 0.000 description 4
XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
229940098773 bovine serum albumin Drugs 0.000 description 4
239000000872 buffer Substances 0.000 description 4
201000011510 cancer Diseases 0.000 description 4
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
235000021240 caseins Nutrition 0.000 description 4
230000007515 enzymatic degradation Effects 0.000 description 4
238000006911 enzymatic reaction Methods 0.000 description 4
230000005284 excitation Effects 0.000 description 4
238000011534 incubation Methods 0.000 description 4
-1 l~minin Polymers 0.000 description 4
235000019833 protease Nutrition 0.000 description 4
238000011160 research Methods 0.000 description 4
238000001179 sorption measurement Methods 0.000 description 4
210000004881 tumor cell Anatomy 0.000 description 4
208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 3
208000033222 Biliary cirrhosis primary Diseases 0.000 description 3
101710088194 Dehydrogenase Proteins 0.000 description 3
102000005741 Metalloproteases Human genes 0.000 description 3
108010006035 Metalloproteases Proteins 0.000 description 3
208000012654 Primary biliary cholangitis Diseases 0.000 description 3
102000004357 Transferases Human genes 0.000 description 3
108090000992 Transferases Proteins 0.000 description 3
DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 3
238000013459 approach Methods 0.000 description 3
229910052786 argon Inorganic materials 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000007850 degeneration Effects 0.000 description 3
238000011161 development Methods 0.000 description 3
230000029087 digestion Effects 0.000 description 3
230000006862 enzymatic digestion Effects 0.000 description 3
239000012530 fluid Substances 0.000 description 3
125000000524 functional group Chemical group 0.000 description 3
239000000499 gel Substances 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
230000002401 inhibitory effect Effects 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
238000012216 screening Methods 0.000 description 3
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
238000012546 transfer Methods 0.000 description 3
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
102000008186 Collagen Human genes 0.000 description 2
108010035532 Collagen Proteins 0.000 description 2
208000016192 Demyelinating disease Diseases 0.000 description 2
206010012305 Demyelination Diseases 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
108010031186 Glycoside Hydrolases Proteins 0.000 description 2
102000005744 Glycoside Hydrolases Human genes 0.000 description 2
102000004157 Hydrolases Human genes 0.000 description 2
108090000604 Hydrolases Proteins 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
102000016943 Muramidase Human genes 0.000 description 2
108010014251 Muramidase Proteins 0.000 description 2
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
108010004729 Phycoerythrin Proteins 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
239000012979 RPMI medium Substances 0.000 description 2
230000009102 absorption Effects 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
150000001299 aldehydes Chemical class 0.000 description 2
108010004469 allophycocyanin Proteins 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
230000008033 biological extinction Effects 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
230000003306 cell dissemination Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
229920001436 collagen Polymers 0.000 description 2
230000021615 conjugation Effects 0.000 description 2
238000004163 cytometry Methods 0.000 description 2
239000003480 eluent Substances 0.000 description 2
238000009585 enzyme analysis Methods 0.000 description 2
238000001952 enzyme assay Methods 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
230000003301 hydrolyzing effect Effects 0.000 description 2
230000003100 immobilizing effect Effects 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
230000006872 improvement Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
229960000274 lysozyme Drugs 0.000 description 2
239000004325 lysozyme Substances 0.000 description 2
235000010335 lysozyme Nutrition 0.000 description 2
239000000463 material Substances 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
201000006417 multiple sclerosis Diseases 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
239000008188 pellet Substances 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
108060006184 phycobiliprotein Proteins 0.000 description 2
229920003053 polystyrene-divinylbenzene Polymers 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
230000002797 proteolythic effect Effects 0.000 description 2
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
238000006862 quantum yield reaction Methods 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical class [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
238000003260 vortexing Methods 0.000 description 2
RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 1
ZKRFOXLVOKTUTA-KQYNXXCUSA-N 9-(5-phosphoribofuranosyl)-6-mercaptopurine Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=S)=C2N=C1 ZKRFOXLVOKTUTA-KQYNXXCUSA-N 0.000 description 1
QQKKFVXSQXUHPI-NBVRZTHBSA-N Acidissiminol epoxide Chemical compound O1C(C)(C)C1CC(O)C(/C)=C/COC(C=C1)=CC=C1CCNC(=O)C1=CC=CC=C1 QQKKFVXSQXUHPI-NBVRZTHBSA-N 0.000 description 1
208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
102000004400 Aminopeptidases Human genes 0.000 description 1
108090000915 Aminopeptidases Proteins 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
102000004452 Arginase Human genes 0.000 description 1
108700024123 Arginases Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
238000000035 BCA protein assay Methods 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
102000004308 Carboxylic Ester Hydrolases Human genes 0.000 description 1
108090000863 Carboxylic Ester Hydrolases Proteins 0.000 description 1
102000005367 Carboxypeptidases Human genes 0.000 description 1
108010006303 Carboxypeptidases Proteins 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010014258 Elastin Proteins 0.000 description 1
102000016942 Elastin Human genes 0.000 description 1
101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
102000005593 Endopeptidases Human genes 0.000 description 1
108010059378 Endopeptidases Proteins 0.000 description 1
108010062466 Enzyme Precursors Proteins 0.000 description 1
102000010911 Enzyme Precursors Human genes 0.000 description 1
108090000371 Esterases Proteins 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
101001126084 Homo sapiens Piwi-like protein 2 Proteins 0.000 description 1
108010003272 Hyaluronate lyase Proteins 0.000 description 1
102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 1
102100021496 Insulin-degrading enzyme Human genes 0.000 description 1
108090000828 Insulysin Proteins 0.000 description 1
102000004195 Isomerases Human genes 0.000 description 1
108090000769 Isomerases Proteins 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
108010013563 Lipoprotein Lipase Proteins 0.000 description 1
102100022119 Lipoprotein lipase Human genes 0.000 description 1
102000043129 MHC class I family Human genes 0.000 description 1
108091054437 MHC class I family Proteins 0.000 description 1
102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
206010027476 Metastases Diseases 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
102100037369 Nidogen-1 Human genes 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
241000282320 Panthera leo Species 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
102100029365 Piwi-like protein 2 Human genes 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
102000016611 Proteoglycans Human genes 0.000 description 1
108010067787 Proteoglycans Proteins 0.000 description 1
101000774655 Protobothrops mucrosquamatus Snake venom metalloproteinase TM-1 Proteins 0.000 description 1
101710086015 RNA ligase Proteins 0.000 description 1
241000219061 Rheum Species 0.000 description 1
FCHAMFUEENBIDH-UHFFFAOYSA-N Severin Natural products CC1CCC2C(C)C3CCC4(O)C(CC5C4CC(O)C6CC(CCC56C)OC(=O)C)C3CN2C1 FCHAMFUEENBIDH-UHFFFAOYSA-N 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
108010046334 Urease Proteins 0.000 description 1
238000005411 Van der Waals force Methods 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
GYMWQLRSSDFGEQ-ADRAWKNSSA-N [(3e,8r,9s,10r,13s,14s,17r)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate;(8r,9s,13s,14s,17r)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.O/N=C/1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(OC(C)=O)C#C)[C@@H]4[C@@H]3CCC2=C\1 GYMWQLRSSDFGEQ-ADRAWKNSSA-N 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
230000002001 anti-metastasis Effects 0.000 description 1
230000000692 anti-sense effect Effects 0.000 description 1
239000002257 antimetastatic agent Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
230000003416 augmentation Effects 0.000 description 1
210000002469 basement membrane Anatomy 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229910001424 calcium ion Inorganic materials 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
230000001364 causal effect Effects 0.000 description 1
230000020411 cell activation Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000002967 competitive immunoassay Methods 0.000 description 1
238000006482 condensation reaction Methods 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
235000011180 diphosphates Nutrition 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000000975 dye Substances 0.000 description 1
229920002549 elastin Polymers 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000009881 electrostatic interaction Effects 0.000 description 1
229940066758 endopeptidases Drugs 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000007824 enzymatic assay Methods 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
238000001215 fluorescent labelling Methods 0.000 description 1
108020005243 folate receptor Proteins 0.000 description 1
102000006815 folate receptor Human genes 0.000 description 1
230000000477 gelanolytic effect Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
150000002340 glycosyl compounds Chemical class 0.000 description 1
229960002773 hyaluronidase Drugs 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000005304 joining Methods 0.000 description 1
229910052743 krypton Inorganic materials 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
239000003475 metalloproteinase inhibitor Substances 0.000 description 1
230000009401 metastasis Effects 0.000 description 1
230000001394 metastastic effect Effects 0.000 description 1
206010061289 metastatic neoplasm Diseases 0.000 description 1
239000011325 microbead Substances 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
229940126619 mouse monoclonal antibody Drugs 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
108010008217 nidogen Proteins 0.000 description 1
QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
229940066734 peptide hydrolases Drugs 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
230000010287 polarization Effects 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
229920000193 polymethacrylate Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920006380 polyphenylene oxide Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
238000002731 protein assay Methods 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
230000009103 reabsorption Effects 0.000 description 1
239000011535 reaction buffer Substances 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000013214 routine measurement Methods 0.000 description 1
238000011896 sensitive detection Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
241000894007 species Species 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
238000006276 transfer reaction Methods 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
108010072415 tumor necrosis factor precursor Proteins 0.000 description 1
238000012800 visualization Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA 2189486 1996-11-04 1996-11-04 Analyse de l'activite enzymatique utilisant des substrats immobilises, marques par fluorescence Abandoned CA2189486A1 (fr)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
CA 2189486 CA2189486A1 (fr)	1996-11-04	1996-11-04	Analyse de l'activite enzymatique utilisant des substrats immobilises, marques par fluorescence
EP97911088A EP0951562A1 (fr)	1996-11-04	1997-11-04	Substrats a marquage fluorescent et leur utilisation pour analyser une activite enzymatique par cytometrie de flux
AU48595/97A AU4859597A (en)	1996-11-04	1997-11-04	Fluorescence-labeled substrates and their use to analyze enzyme activity using flow cytometry
PCT/CA1997/000823 WO1998020153A1 (fr)	1996-11-04	1997-11-04	Substrats a marquage fluorescent et leur utilisation pour analyser une activite enzymatique par cytometrie de flux
CA 2220656 CA2220656A1 (fr)	1996-11-04	1997-11-04	Substrats marques par fluorescence et leur emploi pour analyser l'activite enzymatique par cytometrie de flux

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA 2189486 CA2189486A1 (fr)	1996-11-04	1996-11-04	Analyse de l'activite enzymatique utilisant des substrats immobilises, marques par fluorescence

Publications (1)

Publication Number	Publication Date
CA2189486A1 true CA2189486A1 (fr)	1998-05-04

Family

ID=4159198

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2189486 Abandoned CA2189486A1 (fr)	1996-11-04	1996-11-04	Analyse de l'activite enzymatique utilisant des substrats immobilises, marques par fluorescence

Country Status (4)

Country	Link
EP (1)	EP0951562A1 (fr)
AU (1)	AU4859597A (fr)
CA (1)	CA2189486A1 (fr)
WO (1)	WO1998020153A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN111742209A (zh) *	2018-12-21	2020-10-02	索尼公司	粒子确认方法、粒子捕获芯片、以及粒子分析系统

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6251691B1 (en)	1996-04-25	2001-06-26	Bioarray Solutions, Llc	Light-controlled electrokinetic assembly of particles near surfaces
US9709559B2 (en)	2000-06-21	2017-07-18	Bioarray Solutions, Ltd.	Multianalyte molecular analysis using application-specific random particle arrays
US7262063B2 (en)	2001-06-21	2007-08-28	Bio Array Solutions, Ltd.	Directed assembly of functional heterostructures
ES2712173T3 (es)	2001-10-15	2019-05-09	Bioarray Solutions Ltd	Análisis multiplexado de loci polimórficos mediante consulta simultánea y detección mediada por enzimas
US7041453B2 (en)	2002-08-22	2006-05-09	Bioarray Solutions Ltd.	Molecular constructs and methods of use for detection of biochemical reactions
WO2004047007A1 (fr)	2002-11-15	2004-06-03	Bioarray Solutions, Ltd.	Analyse d'images de reseaux, acces securise a ces images et transmission de ces images
PT1664722E (pt)	2003-09-22	2011-12-28	Bioarray Solutions Ltd	Polielectrólito imobilizado à superfície com grupos funcionais múltiplos capazes de se ligarem covalentemente às biomoléculas
EP1692298A4 (fr)	2003-10-28	2008-08-13	Bioarray Solutions Ltd	Optimisation de l'analyse de l'expression genique a l'aide de sondes de capture immobilisees
US7848889B2 (en)	2004-08-02	2010-12-07	Bioarray Solutions, Ltd.	Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
WO2010013138A2 (fr) *	2008-07-28	2010-02-04	Mnd Diagnostics, Ltd.	Méthodes et compositions destinées à la détection d'un agent pathogène, d'une maladie, d'un état pathologique, ou d'un biomarqueur se rapportant à ceux-ci
US11662312B2 (en) *	2017-06-27	2023-05-30	Coriolis Pharma Research GmbH	Polysorbate quantification assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1339812C (fr) *	1988-02-19	1998-04-14	Tamami Koyama	Substance de remplissage utilisee pour mesurer l'activite enzymatique, colonne remplie avec cette substance et methode pour l'activite enzymatique au moyen de cette colonne
NO164622C (no) *	1988-05-11	1990-10-24	Tore Lindmo	Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav.
US5416003A (en) *	1993-04-14	1995-05-16	Litmus Concepts, Inc.	Reporter enzyme release technology: methods of assaying for the presence of aspartic proteases and other hydrolytic enzyme activities

1996
- 1996-11-04 CA CA 2189486 patent/CA2189486A1/fr not_active Abandoned
1997
- 1997-11-04 AU AU48595/97A patent/AU4859597A/en not_active Abandoned
- 1997-11-04 WO PCT/CA1997/000823 patent/WO1998020153A1/fr not_active Ceased
- 1997-11-04 EP EP97911088A patent/EP0951562A1/fr not_active Withdrawn

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN111742209A (zh) *	2018-12-21	2020-10-02	索尼公司	粒子确认方法、粒子捕获芯片、以及粒子分析系统
US12313639B2 (en)	2018-12-21	2025-05-27	Sony Corporation	Particle confirming method, particle trapping chip, and particle analyzing system

Also Published As

Publication number	Publication date
WO1998020153A1 (fr)	1998-05-14
EP0951562A1 (fr)	1999-10-27
AU4859597A (en)	1998-05-29

Legal Events

Date	Code	Title	Description
1999-11-04	FZDE	Dead

Publication	Publication Date	Title
KR101210215B1 (ko)	2012-12-07	효소 검출 기법
JP5184547B2 (ja)	2013-04-17	酵素検出技術
JPS6188155A (ja)	1986-05-06	フイコビリタンパク質による螢光エネルギ−転位
CN101416057B (zh)	2013-06-05	酶检测技术
EP0951562A1 (fr)	1999-10-27	Substrats a marquage fluorescent et leur utilisation pour analyser une activite enzymatique par cytometrie de flux
JP2009532058A5 (fr)	2012-10-04
CA2554441A1 (fr)	2005-08-18	Systemes, methodes et reactifs pour la detection d'agents biologiques et chimiques au moyen d'une imagerie et d'une generation de surface dynamique
St‐Pierre et al.	1996	Flow cytometric analysis of gelatinase B (MMP‐9) activity using immobilized fluorescent substrate on microspheres
US20030013116A1 (en)	2003-01-16	Multiplex protein interaction determinations using glutathione-GST binding
US7094528B2 (en)	2006-08-22	Magnetic enzyme detection techniques
US20030153011A1 (en)	2003-08-14	Methods and reagents for conducting multiplexed assays of multiple analytes
EP2778230B1 (fr)	2018-07-04	Compositions et procédés permettant d'effectuer des analyses
CA2220656A1 (fr)	1998-05-04	Substrats marques par fluorescence et leur emploi pour analyser l'activite enzymatique par cytometrie de flux
CA2105698A1 (fr)	1994-03-17	Methode de dosage par piegeage d'un marqueur dans un essai non separatif